Clinical Trial Update: Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients [Phase 3]

View source ↗

Summary

Phase 3 trial in paediatric renal transplant recipients evaluating early everolimus with reduced calcineurin inhibitors and early steroid elimination versus sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prevention of Acute Rejection in Paediatric Renal Transplant Patients
• Renal Transplant Recipients

Drugs mentioned

• Calcineurin inhibitors
• Everolimus (everolimus)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• steroids

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Prevention of Acute Rejection in Paediatric Recipients of a Renal Transplant | Phase 3 | Status: COMPLETED | Results posted: 2019-05-31